Overview

Phenylketonuria, Oxidative Stress, and BH4

Status:
Terminated

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see how tetrahydrobiopterin therapy (BH4; also known as sapropterin dihydrochloride or Kuvan) affects measures of oxidative stress and endothelial function in patients with Phenylketonuria (PKU).

Phase:

Phase 2

Details

Lead Sponsor:

Emory University

Treatments:

Verapamil